Identification of an oculomotor biomarker of preclinical Huntington disease
- 8 August 2006
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (3) , 485-487
Abstract
The authors examined oculomotor function to identify a biomarker of disease progression in genetically confirmed preclinical and early clinical Huntington disease (HD). Initiation deficits of voluntary-guided, but not reflexive, saccades were characteristic of preclinical HD. Saccadic slowing and delayed reflexive saccades were demonstrated in clinical but not preclinical HD. Saccadic measures provide biomarkers of disease progression in both preclinical and early clinical stages of HD.Keywords
This publication has 9 references indexed in Scilit:
- Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodiesBrain, 2005
- Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s diseaseVision Research, 2004
- A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthClinical Genetics, 2004
- Using saccades as a research tool in the clinical neurosciencesBrain, 2004
- Hypometric primary saccades and increased variability in visually-guided saccades in Huntington’s diseaseNeuropsychologia, 2003
- Clinical correlation of striatal 1H MRS changes in Huntington’s diseaseNeurology, 1999
- Ocular motor abnormalities in Huntington's diseaseVision Research, 1997
- Eye movements in monkeys with local dopamine depletion in the caudate nucleus. II. Deficits in voluntary saccadesJournal of Neuroscience, 1995
- Huntington diseaseNeurology, 1979